IMPCL Ties Up With Government E-Market Portal To Sell Its Products Online

Mumbai : The Indian Medicines Pharmaceutical Corporation Limited (IMPCL), the public sector manufacturing unit of the Union Ministry of Ayush, has tied up with the government e-market (GeM) portal for selling its products online.

The deal between IMPCL and GeM was finalised on March 03, 2021 when GeM created 31 categories covering 311 medicines, which are live in the marketplace and IMPCL can now upload these medicines on GeM portal, said the statement issued by the Union Ministry of Ayush.

IMPCL, the Rs. 100 crore turnovers PSU of the Union Ministry of Ayush, is one of the most trusted manufacturers of Ayush medicines in the country, and is known for the authenticity of its formulations. Following the tie-up, ayurvedic and Unani medicines of IMPCL will figure on the GeM portal to hundreds of government sector buyers at prices finalised by the Union ministry of finance, it further stated.

This will facilitate quick procurement of these medicines by Central/state government institutions for their healthcare programmes. Thus, this tie-up between GeM & IMPCL also helps to streamline the procurement and distribution of ayurvedic and Unani medicines by state units.

The thousands of patients and other clients who visit government Ayush hospitals every day stand to gain because of this increased availability of such medicines even in far-flung Ayush hospitals and clinics.

The Central government has approved 12,500 Ayush health and wellness centres to be operationalized by Union Ministry of Ayush through State/UT governments under Centrally Sponsored Scheme of National Ayush Mission (NAM) in a phased manner by the year 2023-24. It is envisaged to upgrade Ayush dispensaries and sub-health centres identified by state/UT governments as Ayush health and wellness centres for providing Ayush based preventive, primitive, curative and rehabilitative care.

  • Related Posts

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    India’s $30-billion pharma industry is staring at a fresh challenge after US President Donald Trump announced that generic medicines imported into the US would face tariffs of 100% from Aug…

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    New Delhi: A joint operation by the Delhi Police Crime Branch, the Central Drugs Standard Control Organisation (CDSCO) and the Gautam Buddha Nagar District Drug Department uncovered a suspected illegal…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

    Fake Medicines Worth Over Rs 5 Crore Seized From Factory In Uttarakhand’s Dehradun

    Fake Medicines Worth Over Rs 5 Crore Seized From Factory In Uttarakhand’s Dehradun

    A ‘Fatal Flaw’ might be lurking in apparently Healthy Heart- Dr Devi Shetty

    A ‘Fatal Flaw’ might be lurking in apparently Healthy Heart- Dr Devi Shetty

    CDSCO declares 159 drug samples as NSQs in June

    CDSCO declares 159 drug samples as NSQs in June